Bertech Pharma Ltd. announced today that Dr. David Durack has joined its Scientific Advisory Board.
“The addition of Dr. Durack will further diversify the outstanding talents and wide‐ranging experience that our Scientific Advisory Board already brings to Bertech,” said Mr. Bern Philip, President and CEO of Bertech Pharma. . “Dr Durack is widely respected and experienced in the Pharmaceutical Industry, and will provide Bertech with additional insight and perspectives relating to Bertech’s development of diagnostics to detect and monitor treatment of colorectal cancer.”
About Dr. Durack
Dr. David Durack is Consulting Professor of Medicine at Duke University, and was Senior Vice President, Corporate Medical Affairs and Chief Medical Officer at Becton Dickinson & Co. (retired 10/2012). Education: Correspondence School of West Australia; Scotch College, WA; University of WA medical degree ’69; Rhodes Scholar at Oxford University, Doctor of Philosophy ’73. Internship and residency at Radcliffe Infirmary, Oxford and Royal Postgraduate Medical School, Hammersmith Hospital, London. Research: pathogenesis and chemotherapy of bacterial and fungal infections; Oxford University doctoral thesis entitled “Experimental Endocarditis”. Chief Resident and faculty member, Dept of Medicine, University of Washington, ’74-’77. Chief, Division of Infectious Diseases and International Health and Professor of Medicine, Duke University, ’77-’95. He is a Fellow of the Royal College of Physicians (UK), the Royal Australasian College of Physicians, and the American College of Physicians; he has published more than 230 articles and textbook chapters and co-edited several textbooks. Dr. Durack has been elected to the American Society for Clinical Investigation, the Council of the Infectious Diseases Society of America, and the American Academy of Microbiology. He has served on an FDA Review Panel, the Joint Commission Resources Board of Directors, and as Chairman of the Board, ASM Resources; he is currently a Director for PixelEXX Systems Inc. He has 17 years’ experience as Medical Affairs functional leader and executive officer in the medical devices and diagnostics industry.